Portfoliotracker

Jade Biosciences, Inc.

JBIO · NASDAQCM · Healthcare Biotechnology 30/100 E

15,34 $
▼ −0,80 (−4,99 %)
Pre-market delayed by 15 min
Price as of 16. 11. 22:00, fetched 17. 11. 13:52
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score30 / 100 Market cap936 mil. $ P/E– Forward P/E-6,8 P/S– P/B2,1 EV/EBITDA– Dividend yield– FCF yield-13,20 % EPS-1,92 $ Net margin0,0 % Return on equity– Beta– Debt / equity0,00
52-week range 10,98 to 28,00
3-month average volume0,9 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.

Employees
55
Country
United States
Fiscal year end
31. 12.
Data since
30. 6. 2021

Explore further

Similar companies GLUETYRADSGNABOSEWTX

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account